Cite

HARVARD Citation

    Campone, M. et al. (n.d.). 1874 Phase 1b/2 study results for masitinib plus gemcitabine and carboplatin in advanced triple negative breast cancer. European journal of cancer. pp. S290-S291. [Online]. 
  
Back to record